193 related articles for article (PubMed ID: 6240280)
1. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.
Bautista AP; Buckler PW; Towler HM; Dawson AA; Bennett B
Br J Haematol; 1984 Dec; 58(4):679-87. PubMed ID: 6240280
[TBL] [Abstract][Full Text] [Related]
2. Platelet dynamics in chronic liver disease using the 111Indium oxine label.
Toghill PJ; Green S
Gut; 1983 Jan; 24(1):49-52. PubMed ID: 6401256
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of beta-thromboglobulin in patients with high platelet count.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
[TBL] [Abstract][Full Text] [Related]
4. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
[TBL] [Abstract][Full Text] [Related]
5. Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods.
Vallabhajosula S; Machac J; Goldsmith SJ; Lipszyc H; Badimon L; Rand J; Fuster V
J Nucl Med; 1986 Nov; 27(11):1669-74. PubMed ID: 3095509
[TBL] [Abstract][Full Text] [Related]
6. Platelet function in patients with high platelet counts.
Ginsburg AD
Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
[TBL] [Abstract][Full Text] [Related]
7. [Technic of radioactive labeling of autologous human thrombocytes using 111-indium-oxine and 111-indium-oxine-sulfate and their clinical use].
Jäger E; Kolbe H; Silberbauer K; Sinzinger H; Höfer R
Wien Klin Wochenschr; 1984 Feb; 96(3):106-12. PubMed ID: 6426171
[TBL] [Abstract][Full Text] [Related]
8. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
[TBL] [Abstract][Full Text] [Related]
9. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in renal transplantation. Diagnostic use of homologous platelet labelling with 111In oxine.
Dodd NJ; Clarke MB; Bewick M; Weston MJ
Nephron; 1983; 34(1):42-4. PubMed ID: 6406919
[TBL] [Abstract][Full Text] [Related]
11. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
Brodsky I; Kahn SB; Ross EM; Petkov G
Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
[No Abstract] [Full Text] [Related]
12. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
[TBL] [Abstract][Full Text] [Related]
13. An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets.
Wessels P; Heyns AD; Pieters H; Lötter MG; Badenhorst PN
Eur J Nucl Med; 1985; 10(11-12):522-7. PubMed ID: 3928383
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia.
Schmidt KG; Rasmussen JW; Bekker C; Madsen PE
Scand J Haematol; 1985 Jan; 34(1):39-46. PubMed ID: 3918341
[TBL] [Abstract][Full Text] [Related]
15. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura.
Schmidt KG; Rasmussen JW
Scand J Haematol; 1985 Jan; 34(1):47-56. PubMed ID: 3918342
[TBL] [Abstract][Full Text] [Related]
17. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy.
Minar E; Ehringer H; Ahmadi R; Dudczak R; Porenta G
Thromb Haemost; 1987 Aug; 58(2):718-23. PubMed ID: 2960029
[TBL] [Abstract][Full Text] [Related]
18. The clinical use of platelet scintigraphy with 111-In-oxine.
Kessler C; Reuther R; Berentelg J; Kimmig B
J Neurol; 1983; 229(4):255-61. PubMed ID: 6192227
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
20. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
